Secondary parkinsonism due to drugs, vascular lesions, tumors, trauma, and other insults.
Höllerhage M.
Int Rev Neurobiol. 2019;149:377-418. doi: 10.1016/bs.irn.2019.10.010. Epub 2019 Nov 21.
Drug-induced parkinsonism: diagnosis and treatment.
Conn H, Jankovic J.
Expert Opin Drug Saf. 2024 Dec;23(12):1503-1513. doi: 10.1080/14740338.2024.2418950. Epub 2024 Oct 25.
Secondary parkinsonism.
Terashi H, Taguchi T, Aizawa H.
Nihon Rinsho. 2017 Jan;75(1):63-70.
The diagnosis of Parkinson's disease.
Tolosa E, Wenning G, Poewe W.
Lancet Neurol. 2006 Jan;5(1):75-86. doi: 10.1016/S1474-4422(05)70285-4.
Nonmotor Symptoms in Vascular and Other Secondary Parkinsonism.
Levin OS, Chimagomedova AS, Skripkina NA, Lyashenko EA, Babkina OV.
Int Rev Neurobiol. 2017;134:1303-1334. doi: 10.1016/bs.irn.2017.05.016. Epub 2017 Jul 4.
Parkinsonism--neuropathology.
Lewis PD.
Br Med J. 1971 Sep 18;3(5776):690-2. doi: 10.1136/bmj.3.5776.690.
Parkinsonism secondary to neurosyphilis.
Carr J.
Mov Disord. 2009 Jul 15;24(9):1407. doi: 10.1002/mds.22615.
Secondary (toxic) parkinsonism as model of Parkinson's disease.
Riederer P, Sofic E, Heuschneider G, Benedetti MS, Dostert P.
Funct Neurol. 1988 Oct-Dec;3(4):449-57.
MPTP-induced parkinsonism.
Stern Y.
Prog Neurobiol. 1990;34(2):107-14. doi: 10.1016/0301-0082(90)90003-y.
Drug-Induced Parkinsonism.
Garg K, Rajan R, Singh M.
Neurol India. 2021 Mar-Apr;69(2):437-438. doi: 10.4103/0028-3886.314567.
